| Bristol Myers Squibb Signs US$11 B Partnership with BioNTech for Next-generation Bispecific Antibody |
Abstract
pdf
html
|
|
Lucy Haggerty |
|
| Novo Nordisk Signs US$2.2B Licensing Pact with Septerna for Obesity |
Abstract
pdf
html
|
|
Naini Anand |
|
| Pfizer and 3SBio Forge US$6 B Oncology Alliance to Advance Bispecific Antibody Therapy |
Abstract
pdf
html
|
|
Hitesh Udar |
|
| Regeneron Inks US$2.01 B Deal for Hansoh’s Late-Stage Obesity Drug Candidate |
Abstract
pdf
html
|
|
Hitesh Udar |
|
| Astellas Signs US$1.5 B Deal with Evopoint Biosciences for Novel CLDN18.2 ADC |
Abstract
pdf
html
|
|
Swati Sharan |
|
| Lilly Signs US$870 M Licensing Pact with Camurus for Long-Acting FluidCrystal® Incretins |
Abstract
pdf
html
|
|
Naini Anand |
|
| Sanofi to Acquire Blueprint Medicines for up to US$9.5 B |
Abstract
pdf
html
|
|
Lucy Haggerty |
|
| Sanofi to Acquire Vigil Neuroscience for up to US$470 M |
Abstract
pdf
html
|
|
Ayush Saxena |
|
